Two Seas Capital reported a 8% stake in Adaptimmune Therapeutics ADAPY · 123,178,110 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 8%
Last report: 5.8% · filed 25/02/14
Shares held: 123,178,110 sh
Class: Ordinary Shares, par value GBP 0.001 per share
Stock: Adaptimmune Therapeutics ADAPY
Holder: Two Seas Capital
Event date: 25/03/31
Filed: 25/05/15

8% stake · +2.2pp from the last report

Stake: 8%
Last report: 5.8%
Since last report: +2.2pp

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Two Seas Capital's other 5% stake reports

Two Seas Capital
5% stakeSable Offshore
5% stake
Sable Offshore
SOC
5.4% stake
8,377,636 sh
5.4% stake
Filed 08/14
Two Seas Capital
5% stakeCalumet
5% stake
Calumet
CLMT
7.5% stake
6,619,708 sh
7.5% stake
Filed 08/14
Two Seas Capital
5% stakeQuantum
5% stake
Quantum
QMCO
6.3% stake
2,488,535 sh
6.3% stake
Filed 08/14
Two Seas Capital
5% stakeNektar Therapeutics
5% stake
Nektar Therapeutics
NKTR
9.1% stake
3,092,234 sh
9.1% stake
Filed 08/14
Two Seas Capital
5% stakePAVmed
5% stake
PAVmed
PAVM
9.99% stake
657,219 sh
9.99% stake
Filed 05/15